Cartesian Therapeutics, Inc. (RNAC)
10.17
+0.13
(+1.29%)
USD |
NASDAQ |
Aug 24, 16:00
10.17
0.00 (0.00%)
After-Hours: 20:00
Cartesian Therapeutics Price to Book Value
Price to Book Value Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Price to Book Value Data
| Date | Value |
|---|---|
| March 28, 2025 | 462.04 |
| March 27, 2025 | 456.32 |
| March 26, 2025 | 472.85 |
| March 25, 2025 | 505.89 |
| March 24, 2025 | 506.53 |
| March 21, 2025 | 510.02 |
| March 20, 2025 | 506.21 |
| March 19, 2025 | 491.28 |
| March 18, 2025 | 463.95 |
| March 17, 2025 | 458.86 |
| March 14, 2025 | 502.08 |
| March 13, 2025 | 527.82 |
| March 12, 2025 | 555.47 |
| March 11, 2025 | 573.90 |
| March 10, 2025 | 569.13 |
| March 07, 2025 | 584.70 |
| March 06, 2025 | 567.22 |
| March 05, 2025 | 569.45 |
| March 04, 2025 | 566.91 |
| March 03, 2025 | 556.10 |
| February 28, 2025 | 598.68 |
| February 27, 2025 | 572.31 |
| February 26, 2025 | 572.94 |
| February 25, 2025 | 605.99 |
| February 24, 2025 | 604.40 |
| Date | Value |
|---|---|
| February 21, 2025 | 611.39 |
| February 20, 2025 | 623.15 |
| February 19, 2025 | 614.57 |
| February 18, 2025 | 620.29 |
| February 14, 2025 | 625.06 |
| February 13, 2025 | 604.72 |
| February 12, 2025 | 601.23 |
| February 11, 2025 | 588.51 |
| February 10, 2025 | 588.20 |
| February 07, 2025 | 583.43 |
| February 06, 2025 | 597.73 |
| February 05, 2025 | 614.89 |
| February 04, 2025 | 597.41 |
| February 03, 2025 | 632.05 |
| January 31, 2025 | 613.62 |
| January 30, 2025 | 615.84 |
| January 29, 2025 | 611.08 |
| January 28, 2025 | 635.23 |
| January 27, 2025 | 617.11 |
| January 24, 2025 | 610.12 |
| January 23, 2025 | 617.11 |
| January 22, 2025 | 605.67 |
| January 21, 2025 | 630.78 |
| January 17, 2025 | 612.98 |
| January 16, 2025 | 601.54 |
Price to Book Ratio Definition
Price to book value is a valuation ratio that is measured by stock price / book value per share. The book value is essentially the tangible accounting value of a firm compared to the market value that is shown.
Price to Book Value Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Price to Book Value Benchmarks
| Allogene Therapeutics, Inc. | 1.611 |
| Beam Therapeutics, Inc. | 2.742 |
| C4 Therapeutics, Inc. | 2.043 |
| Kyverna Therapeutics, Inc. | 3.061 |
| Arrowhead Pharmaceuticals, Inc. | 26.30 |
Price to Book Value Related Metrics
| PS Ratio | 187.17 |
| PEG Ratio | -0.0021 |
| Price | 10.17 |
| Earnings Yield | -58.40% |
| Market Cap | 305.49M |
| PEGY Ratio | -0.0021 |